Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
|
|
Reuters (10.21.09) - Thursday, October 22, 2009
Tan Ee Lyn
Elite controllers remain healthy, with no signs of HIV-related illness and no need for treatment, for as long as 10 years after infection. Scientists hope that studying them will unlock the secret of their robust immune systems - knowledge that could one day inform the development of a successful AIDS vaccine.
So far, blood and data from some 2,000 such patients, also known as "long-term nonprogressers," are being closely examined. Most of these subjects are from the United States and Canada.
"There are many [elite controllers] in China," said Yu Xu, assistant professor of medicine at Massachusetts General Hospital and Harvard Medical School, who addressed the Paris conference. "There are about 400 villagers infected in the 1990s and who are surviving until now. They have very low viral loads."
"On average, an HIV-infected person has 30,000 [viral] copies," Yu said. Elite controllers, by contrast, are classified into two groups: those who have a viral count of 2,000 or less, and those whose count is below 50.
At a news conference, Yu's colleague Mathias Lichterfeld said controllers seem to have superior dendritic cells, a type of immune system cell that appears to be an access point for HIV. Some of the patients' dendritic cells show higher activity of certain receptors, or molecular doorways. "This offers potentially the opportunity to manipulate these two receptors to advance vaccine studies," he said, adding that the CD8 T- cells of controllers also seem to have unusually strong responses to HIV.
091022
AD091820
Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.